Evidence map›Paper›PMID 24289105›Full record

ArticleMalaria journal2013

Reticulocyte-prone malaria parasites predominantly invade CD71hi immature cells: implications for the development of an in vitro culture for Plasmodium vivax.

Lorena Martín-Jaular, Aleix Elizalde-Torrent, Richard Thomson-Luque, Mireia Ferrer, Jose C Segovia, Esperanza Herreros-Aviles, Carmen Fernández-Becerra, Hernando A Del Portillo

Open access · goldAbstract read
In one paragraph

Article in Malaria journal, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Immunoregulation role of the erythroid cells.Frontiers in immunology · 2024
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Advancing Key Gaps in the Knowledge ofFrontiers in cellular and infection microbiology · 2022
    Review
  9. Rodent Malaria Erythrocyte Preference Assessment by anFrontiers in cellular and infection microbiology · 2021
    Article
  10. Home Sweet Home:Frontiers in cellular and infection microbiology · 2021
    Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. The Biology ofCold Spring Harbor perspectives in medicine · 2017
    Review
  19. Article
  20. Development in Assay Methods forFrontiers in pharmacology · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Lorena Martín-JaularICREA at Barcelona Centre for International H ealth Research (CRESIB, Hospital Clínic-Universitat de Barcelona)/ISGlobal, Barcelona, Spain. hernandoa.delportillo@cresib.cat.
Aleix Elizalde-Torrent
Richard Thomson-Luque
Mireia Ferrer
Jose C Segovia
Esperanza Herreros-Aviles
Carmen Fernández-Becerra
Hernando A Del Portillo
Barcelona Institute for Global Health · ESCentro de Investigaciones Energéticas, Medioambientales y Tecnológicas · ESGlaxoSmithKline (Spain) · ESUniversitat de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe lack of a continuous in vitro culture system for blood stages of malarial parasites with a unique tropism for reticulocytes, such as Plasmodium vivax and the Plasmodium yoelii 17X reticulocyte-prone strain, hinders research in these organisms. The maturation of reticulocytes into erythrocytes is a complex process involving the selective removal of membrane proteins such as the transferrin receptor, CD71. In order to advance in the characterization of infected cells during experimental infections of BALB/c mice with P. yoelii 17X, CD71 expression in erythroid cells (TER119+) was assessed and in vitro culture of P. yoelii 17X was attempted by adding reticulocytes highly expressing CD71.

methodsBALB/c mice were infected with P. yoelii 17X-GFP transgenic parasites and erythroid cells (TER119+) were analysed in blood, spleen and bone marrow cells. TER119, CD71 and GFP expression was assessed at different points post-infection by flow cytometry. Moreover, in vitro culture of P. yoelli 17X was attempted by adding red blood cells (RBCs) from mice with a pyruvate kinase deficiency, which contain high percentages of CD71hi cells in peripheral blood as compared to healthy animals.

resultsA predominance of erythroid cells lacking expression of CD71 (CD71-) was observed in peripheral blood and spleen in normal and infected animals up to ten days post-infection (pi). At ten days pi, however, a dramatic temporal switch to erythroid cells highly expressing CD71 (CD71hi) was observed in the spleen and at day 15 pi in peripheral blood of the infected cells. A distribution of erythroid cells expressing differently CD71 was noticed in the bone marrow. Yet, similar to peripheral blood and spleen, a predominance of CD71hi cells was observed at 15 days pi. Remarkably, CD71hi cells were the cells predominantly infected in these organs as well as in peripheral blood. Attempts were thus made to culture in vitro the P. yoelli 17X strain by adding RBCs from pyruvate kinase-deficient mice containing high percentages of CD71hi cells in peripheral blood.

conclusionsThe parasite preference for immature cells that are rare in normal peripheral blood could have important implications for the development of an in vitro culture system for P. vivax.

Indexed as

AnimalsAnimals, Genetically ModifiedAntigens, CDCulture TechniquesFemaleFlow CytometryMalariaMalaria, VivaxMiceMice, Inbred BALB CPlasmodium vivaxPlasmodium yoeliiReceptors, TransferrinReticulocytesAntigens, CDCD71 antigenReceptors, Transferrin

Identifiers

PMID24289105
PMCPMC4220676
OpenAlexW2135861155

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.